Published in Drug Week, February 16th, 2007
Results of this study, which were first presented at the American Society of Clinical Oncology 2004 annual meeting, indicate treatment with Saforis significantly reduced the incidence of severe oral mucositis when compared to placebo.
Saforis is an investigational therapy for the treatment and prevention of oral mucositis in patients receiving mucotoxic cancer therapy. Results...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2007-02-16)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.